Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease

Includes bibliographical references (leaves 134-170).

Saved in:
Bibliographic Details
Main Author: Mohammed, Ashraf Allie
Other Authors: Maartens, Gary
Format: Thesis
Language:English
Published: Department of Public Health and Family Medicine 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613303021240320
access_status_str Open Access
author Mohammed, Ashraf Allie
author2 Maartens, Gary
author_browse Maartens, Gary
Mohammed, Ashraf Allie
author_facet Maartens, Gary
Mohammed, Ashraf Allie
author_sort Mohammed, Ashraf Allie
collection Thesis
description Includes bibliographical references (leaves 134-170).
format Thesis
id oai:open.uct.ac.za:11427/9426
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:33:59.204Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Department of Public Health and Family Medicine
publisherStr Department of Public Health and Family Medicine
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/9426 The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease Mohammed, Ashraf Allie Maartens, Gary Ehrlich, Rodney Public Health Includes bibliographical references (leaves 134-170). [Introduction] Meta-analysis of the treatment of latent tuberculosis infection (LTBI) in HIV-infected adults has shown significant reduction in the incidence of tuberculosis in participants with a positive tuberculin skin test (TST), but not in those with a negative TST. However, there are insufficient data on patients with advanced HIV disease from high tuberculosis incidence areas. It is important to exclude tuberculosis prior to such preventive therapy, but this can be difficult in patients with symptomatic HIV disease. A tuberculosis screening instrument is thus needed to ensure that patients placed on preventive therapy do not have tuberculosis. Furthermore, to ensure adherence and avoid drug resistance optimal supervision of the treatment administrations is required. [ Methods ] Patients with clinically advanced HIV disease were screened for active tuberculosis using a symptom questionnaire, measured weight loss, chest radiography, sputum microscopy and culture prior to receiving tuberculosis preventive therapy. Once tuberculosis was excluded, a randomized doubleblind trial was conducted comparing INH with placebo among TST negative status participants with WHO Stage 3 or 4 HIV disease. INH/placebo was administered for 12 months by patient-nominated supervisors. TST-positive participants were given open-label INH. Participants who did not have access to ART were followed up for 24 months with 6-monthly sputum culture and chest radiography. All those enrolled for the trial were required to visit a clinic on a monthly basis for 12 months during the period of weekly intermittent supervised administration of INH/placebo to assess for tuberculosis and adherence. [ Results ] A total of 118 participants were enrolled: TST was negative in 98. Tuberculosis was diagnosed in 11 of 129 patients screened. A simple screening instrument of two or more of the symptoms cough, night sweats or fever, (plus measured weight loss) had a sensitivity of 100% and specificity of 88.1% (against the gold standard of sputum culture) and positive and negative predictive values of 44% and 100%, respectively. In the randomized trial arms, the incidence of tuberculosis was 18/100 person-years (py) in the INH arm and 11.6/100 py in the placebo arm [hazard ratio 1.59, 95% confidence interval (CI) 0.57-49)]. There was no significant difference in mortality, hospitalization rate or CD4+ lymphocyte decline. Patient adherence for INH/placebo was 8 5% and was significantly higher among participants with work-based treatment supervisors than among those who were supervised by home-based or community-based treatment supervisors. The daily self-administered treatment (SAT) of cotrimoxazole (CTX) showed a good adherence especially among the TST positive participants, where a greater benefit in terms of survival among participants with good cotrimoxazole adherence was observed. 2014-11-08T18:08:40Z 2014-11-08T18:08:40Z 2008 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/9426 eng application/pdf Department of Public Health and Family Medicine Faculty of Health Sciences University of Cape Town
spellingShingle Public Health
Mohammed, Ashraf Allie
The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
thesis_degree_str Doctoral
title The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
title_full The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
title_fullStr The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
title_full_unstemmed The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
title_short The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
title_sort efficacy of intermittent directly observed isoniazid in preventing tuberculosis in hiv infected adults with advanced disease
topic Public Health
url http://hdl.handle.net/11427/9426
work_keys_str_mv AT mohammedashrafallie theefficacyofintermittentdirectlyobservedisoniazidinpreventingtuberculosisinhivinfectedadultswithadvanceddisease
AT mohammedashrafallie efficacyofintermittentdirectlyobservedisoniazidinpreventingtuberculosisinhivinfectedadultswithadvanceddisease